The estimated Net Worth of Robert L Burr is at least $756 Thousand dollars as of 15 January 2019. Robert Burr owns over 30,000 units of Amneal Pharmaceuticals Inc stock worth over $756,371 and over the last 17 years Robert sold AMRX stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Robert Burr AMRX stock SEC Form 4 insiders trading
Robert has made over 1 trades of the Amneal Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Robert exercised 30,000 units of AMRX stock worth $196,500 on 15 January 2019.
The largest trade Robert's ever made was exercising 30,000 units of Amneal Pharmaceuticals Inc stock on 15 January 2019 worth over $196,500. On average, Robert trades about 4,286 units every 0 days since 2007. As of 15 January 2019 Robert still owns at least 90,475 units of Amneal Pharmaceuticals Inc stock.
You can see the complete history of Robert Burr stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Robert Burr's mailing address?
Robert's mailing address filed with the SEC is 30831 Huntwood Ave, Hayward, CA 94544, USA.
Insiders trading at Amneal Pharmaceuticals Inc
Over the last 7 years, insiders at Amneal Pharmaceuticals Inc have traded over $867,197,480 worth of Amneal Pharmaceuticals Inc stock and bought 3,818,425 units worth $12,997,905 . The most active insiders traders include Gp A, Llcbonderman Davidcou..., Holdings, Llc Aphc, and International Ltd Fosun. On average, Amneal Pharmaceuticals Inc executives and independent directors trade stock every 18 days with the average trade being worth of $3,857,739. The most recent stock trade was executed by Andrew S Boyer on 14 August 2024, trading 62,711 units of AMRX stock currently worth $491,654.
What does Amneal Pharmaceuticals Inc do?
an american pharmaceutical company, amneal develops and produces affordable medicines. the company was built upon a family tradition of quality and integrity. everything amneal does, across the full spectrum of its business, is in service to these guiding principles. amneal is committed to constantly elevating and refining the value it delivers to its customers and patients around the globe.
What does Amneal Pharmaceuticals Inc's logo look like?
Complete history of Robert Burr stock trades at Hudson Technologies and Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals Inc executives and stock owners
Amneal Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Andrew Boyer,
Executive Vice President - Commercial Operations -
Chintu Patel R.Ph, R.Ph.,
Co-Founder, Co-CEO & Director -
Nikita Shah,
Chief Human Resource Officer, Senior Vice President -
Andrew S. Boyer,
Exec. VP & Chief Commercial Officer of Generics -
Anastasios G. Konidaris,
Exec. VP & CFO -
Joseph Todisco MBA,
Exec. VP & Chief Commercial Officer of Specialty -
Nikita Shah,
Exec. VP and Chief HR Officer & Strategic Planning Officer -
J. Kevin Buchi,
Independent Director -
Ted Nark,
Independent Director -
Emily Alva,
Independent Director -
Gautam Patel,
Director -
Chintu Patel,
Co-Chief Executive Officer, Co-Founder, Director -
Chirag Patel,
President, Co-Chief Executive Officer, Director -
Paul Meister,
Independent Chairman of the Board -
Shlomo Yanai,
Independent Director -
John Kiely,
Independent Director -
Jeffrey George,
Independent Director -
Chintu Patel R.Ph., R.Ph,
Co-Founder, Co-CEO & Director -
Chirag K. Patel,
Co-Founder, Co-CEO, Pres & Director -
Joseph Todisco,
Senior Vice President - Specialty Commercial -
Apurva Saraf,
Senior Vice President - Corporate Development -
Joseph Greer,
Senior Vice President - Global Quality Management -
Stephen Manzano,
Senior Vice President, General Counsel & Corporate Secretary -
Sanjay Jain,
President - India -
Anastasios Konidaris,
Chief Financial Officer, Senior Vice President -
Jason B. Daly Esq.,
Sr. VP, Chief Legal Officer & Corp. Sec. -
Dr. Nikunj Patel,
Head of Ops & Exec. VP of Amneal Pharmaceuticals (India) Pvt Ltd -
Sanjiv Patel,
Sr. VP of Operations -
Stephen J. Manzano,
Sr. VP, Gen. Counsel & Corp. Sec. -
Anthony DiMeo,
Sr. Director of Investor Relations -
Sheldon Hirt,
SVP, GC & Corp. Sec. -
Jean Selden Greene,
Director -
Holdings, Llc Aphc,
10% owner -
Robert L Burr,
Director -
Bryan M. Reasons,
CFO -
Robert A Stewart,
President and CEO -
Dharmendra Rama,
Director -
Janet S. Vergis,
Director -
Peter R Terreri,
Director -
Paul Bisaro,
Executive Chairman -
David A Buchen,
SVP, Chief Legal Officer -
Todd P. Branning,
SVP and CFO -
Pradeep Bhadauria,
SVP, Chief Scientific Officer -
International Ltd Fosun,
10% owner -
Gustavo Pesquin,
See Remarks -
Gp A, Llcbonderman Davidcou...,
-
Tasos Konidaris,
Executive Vice President & CFO -
Jason B. Daly,
SVP, Chief Legal Officer -
Deborah M. Autor,
Director -
Dipan Patel,
-
Tushar Bhikhubhai Patel,
10% owner